Showing 821 - 840 results of 226,013 for search '(( 10 ((mg decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.35s Refine Results
  1. 821

    Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF by Renée H. Fiechter (10230473)

    Published 2021
    “…No serious adverse events occurred. We observed numerical decreases of all infiltrating cell subtypes at week 12, reaching statistical significance for CD68+ sublining macrophages. …”
  2. 822

    Viability of MC3T3-E1 cells treated with different concentration of Mg<sup>2+</sup> (diluted to standard concentrations from the supernatant of Pure Mg, Mg2Ag and Mg10Gd). by Sepideh Mostofi (3147717)

    Published 2016
    “…The pH of the extracts has been adjusted to 7.4. Decrease in viability of MC3T3-E1 cells was detected at concentration of 0.9 to 1.2 mg/mL Mg<sup>2+</sup>. …”
  3. 823
  4. 824
  5. 825
  6. 826

    Decrease in log<sub>10</sub> CFU counts in footpads. by Deepak V. Almeida (227435)

    Published 2013
    “…<p>Decrease in the log<sub>10</sub> CFU counts in the footpads of mice treated with, streptomycin+ rifampin for 5 days a week (STR+RIF 5/7), STR+RIF for 7 days a week (STR+RIF 7/7) and STR+ rifapentine (RPT) (STR+RPT 5/7) compared to untreated controls. …”
  7. 827
  8. 828

    Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3‑Oxo-3,4-dihydro‑2<i>H</i>‑ben... by Shuhei Ikeda (2380180)

    Published 2021
    “…Optimization of the left hand side afforded <b>4f</b> as a promising reversible MAGL inhibitor, which showed potent in vitro MAGL inhibitory activity (IC<sub>50</sub> 6.2 nM), good oral absorption, blood–brain barrier penetration, and significant pharmacodynamic changes (2-arachidonoylglycerol increase and arachidonic acid decrease) at 0.3–10 mg/kg, po. in mice.…”
  9. 829
  10. 830
  11. 831
  12. 832
  13. 833
  14. 834
  15. 835
  16. 836
  17. 837
  18. 838
  19. 839

    CPGF NPs decrease the growth kinetics of breast cancer cells. by Kirtee D. Wani (636463)

    Published 2014
    “…<p>(<b>A</b>) The NPs decreased the number of cells in MDAMB231 and MCF7, indicated by cell growth assay. …”
  20. 840